2014-2018 European Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-France, Germany, Italy, Spain, UK

This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.

Tests Analyzed in the Report Include:

Routine Clinical Chemistry 

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid. 

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

Endocrine Function 

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.

Tumor Markers and Special Chemistry 

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),

Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,

PAP, PSA, Thyroglobulin, Vitamin B-12.

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,PAP, PSA, Thyroglobulin, Vitamin B-12. Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,

Immunofixation, Prealbumin, Protein Electrophoresis.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,

LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene,

Tricyclic Antidepressants.

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers

of clinical chemistry and immunodiagnostic products

by country and individual product.

Geographic Regions

- France

- Germany

- Italy

- Spain

- UK

Competitive Assessments

Strategic assessments of major suppliers and

emerging market entrants, including their sales,

product portfolios, marketing tactics, and new products in.

Market Segmentation Analysis

- Comprehensive market segmentation

analysis, including review of the market

dynamics, trends, structure, size, growth,

and key suppliers, by country.

- Test volume and sales forecasts for over 100 clinical chemistry,

TDM, endocrine, cancer, immunoprotein and abused drug assays,

by country and market segment:

- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Ambulatory Care Centers

Current and Emerging Products

- Analysis of current and emerging clinical chemistry

and immunodiagnostic tests.

- Review of current instrumentation technologies, and a feature comparison

of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging

technologies, and their potential market applications.

- Comprehensive lists of companies developing

or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities

with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 900 pages and 335 tables

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,PAP, PSA, Thyroglobulin, Vitamin B-12.